08:30 - 12:15 | Oral Abstracts 3 | Hall 8a |
08:30 - 10:00 | Future perspectives of patient optimization in heart failure - Sponsored by Boston Scientific | Hall 8b |
08:30 - 12:15 | AF Association Improving AF Outcomes Outside the Lab | Hall 9 |
08:30 - 12:15 | Arrhythmia Alliance Improving care in patients at risk of sudden cardiac death | Hall 11 |
10:45 - 12:15 | The Zero Jargon Science Primer for Clinicians | Hall 8b |
AF Ablation | ||||
Chair: Prof Mark O'Neill | London UK | |||
---|---|---|---|---|
Chair: Dr Arthur Yue | Southampton UK | |||
08:30 | ABLATION OF LONGSTANDING PERSISTENT ATRIAL FIBRILLATION USING THE ACQMAP 3-D MAPPING SYSTEM – AN EARLY SINGLE CENTRE EXPERIENCE | Mr Ewen Shepherd | Newcastle upon Tyne UK | |
08:45 | IMPROVING TARGET IDENTIFICATION OF PERSISTENT ATRIAL FIBRILLATION ABLATION USING SIMULTANEOUS INTRACARDIAC MAPPING | Ms Xin Li | Leicester UK | |
09:00 | ACCURACY OF LEFT ATRIAL BIPOLAR VOLTAGES OBTAINED BY CONFIDENSE MULTIELECTRODE MAPPING IN PATIENTS WITH PERSISTENT ATRIAL FIBRILLATION | Mr Baptiste Maille | Liverpool UK | |
09:15 | THE IMPACT OF THE PRESENCE OF LEFT ATRIAL LOW VOLTAGE AREAS ON OUTCOMES FROM PULMONARY VEIN ISOLATION | Mr Fiyyaz Ahmed-Jushuf | London UK | |
09:30 | POWER, LESION SIZE INDEX AND OESOPHAGEAL TEMPERATURE ALERTS DURING ATRIAL FIBRILLATION ABLATION (PILOT-AF): A RANDOMIZED STUDY | Ms Milena Leo | Oxford UK | |
09:45 | Break | |||
VT, EP & AF Ablation | ||||
10:45 | EFFECT OF ACTIVATION WAVEFRONT ON ELECTROGRAM CHARACTERISTICS DURING VENTRICULAR TACHYCARDIA ABLATION | Ms Claire Martin | Bordeaux FR | |
11:00 | MULTIMODALITY IMAGE RECONSTRUCTION AND FUSION TO GUIDE VT ABLATION | |||
11:15 | APPLICATION OF THE NOVEL ‘SHANGHAI’ DIAGNOSTIC CRITERIA FOR BRUGADA SYNDROME REDUCES THE NUMBER OF DIAGNOSES WITH LOW RISK OF ARRHYTHMIC EVENTS IN INDEX CASES | Mr Greg Mellor | Cambridge UK | |
11:30 | DEVELOPMENT OF ATRIAL FIBRILLATION FOLLOWING ABLATION FOR TYPICAL ATRIAL FLUTTER CANNOT BE PREDICTED BY CONVENTIONAL RISK FACTORS; TIME FOR A RETHINK IN ABLATION STRATEGY? | Mr M Mann | Liverpool UK | |
11:45 | EVOLUTION OF PROMS DATA AND WHAT IT TELLS US ABOUT PATIENTS UNDERGOING CATHETER ABLATION FOR ATRIAL FIBRILLATION | Mr J Girach | Leicester UK | |
12:00 | ATRIAL FIBRILLATION ABLATION AS A DAY-CASE PROCEDURE: THREE-YEAR SINGLE-CENTRE EXPERIENCE | Mr Stefano Bartoletti | Liverpool UK | |
12:15 | Close |
Chair: Prof Martin Cowie | London UK | |||
---|---|---|---|---|
08:30 | How can we treat more CRT-indicated patients with better outcome? The clinical and economic impact of longevity | Dr Jay Wright | Liverpool UK | |
08:50 | The Multisense trial: finally a new perspective for monitoring patients with heart failure | Prof Roy Gardner | Glasgow UK | |
09:10 | A multiparametric approach to efficiently manage patients with Heart Failure: the HeartLogic philosophy | Prof Martin Cowie | London UK | |
09:30 | Can we save time and maximize outcome with Smart CRT Programming at implantation and follow-up? | Dr Alison Seed | Blackpool UK | |
09:50 | Discussion | Prof Martin Cowie | London UK | |
10:00 | Close |
Chair: Dr Dhiraj Gupta | Liverpool UK | |||
---|---|---|---|---|
Chair: Dr Tim Betts | Oxford UK | |||
08:30 | Is there such a thing as having too much choice? Which NOAC to choose for which patient? | Dr Irina Savelieva | London UK | |
09:00 | What constitutes a total contraindication to oral anticoagulation in the NOAC era? Who to refer on for Left Atrial Appendage Occlusion? | Dr Tim Betts | Oxford UK | |
09:30 | Heart Failure in AF: how important is rate control with Beta Blockers? | Dr Dipak Kotecha | Birmingham UK | |
10:00 | Break | |||
Chair: Dr Dhiraj Gupta | Liverpool UK | |||
Chair: Prof Andre Ng | Leicester UK | |||
10:45 | Mobile Apps and Devices: How have these impacted on AF detection and management? | Prof Andre Ng | Leicester UK | |
11:15 | Role of Biomarkers in stratifying stroke risk in AF; should the ABC score trump CHADSVASc score? | Dr Dipak Kotecha | Birmingham UK | |
11:45 | The relationship between AF burden and stroke risk: not what it seems? | Dr Derick Todd | Liverpool UK | |
12:15 | Close |
Chair: Prof Pier Lambiase | London UK | |||
---|---|---|---|---|
Chair: Dr Kim Rajappan | Oxford UK | |||
08:30 | Sudden death post MI: epidemiology and risk | Prof Andre Ng | Leicester UK | |
09:00 | The role of the nurse specialist in SCD treatment/prevention | Mr Craig Russell | Leeds UK | |
09:30 | Management of recurrent VT: drugs and ablation | Prof Prapa Kanagaratnam | London UK | |
10:00 | Break | |||
10:45 | ARVC: what's new in arrhythmia management | Dr Stephen Page | Leeds UK | |
11:15 | Cardiac sarcoidosis: managing risk of sudden cardiac death | Dr Kim Rajappan | Oxford UK | |
11:45 | The role of gene-based pharmacotherapy in preventing SCD - science fiction or reality? | Prof Pier Lambiase | London UK | |
12:15 | Close |
Chair: Dr Malcolm Finlay | London UK | |||
---|---|---|---|---|
Chair: Dr Gwilym Morris | Manchester UK | |||
10:45 | Reintroducing the Cardiac Action Potential - Everything You Need to Know But Were Too Afraid To Ask | Prof Neil Herring | Oxford UK | |
11:00 | How Fat Gives You AF - and what YOU can do about it | Dr Fu Siong Ng | London UK | |
11:30 | Stresses and Strains : the brain, the heart and autonomic feedback | Dr Richard Ang | London UK | |
11:45 | Traffic Jams and arrhythmias : causes and cures from ion channel trafficking | Dr Stephen Harmer | London UK | |
12:15 | Close |